Search research articles
Contact Us
Filters
Showing results (11-20 of 433) with videos related to
Page
of 44
Sort By:
Diabetes
|
August 28, 2012
Comment on: Gögebakan et al. Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11β-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids. Diabetes 2012;61:292-300
Filip K Knop, Mikkel Christensen
Diabetes Research and Clinical Practice
|
June 27, 2018
Extrapancreatic glucagon: Present status
Asger Lund, Filip K Knop
Current Medical Research and Opinion
|
April 3, 2012
Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea
Asger Lund, Filip K Knop
Lancet (London, England)
|
January 10, 2012
The unobtainable placebo: control of independent clinical research by industry?
Mikkel Christensen, Filip K Knop
Vitamins and Hormones
|
November 25, 2010
Incretin-based therapy and type 2 diabetes
Kristine J Hare, Filip K Knop
European Journal of Endocrinology
|
August 2, 2019
A role for exogenous GLP-1 in the management of postprandial hypoglycaemia after Roux-en-Y gastric bypass?
Caroline C Øhrstrøm, Filip K Knop
Acta Psychiatrica Scandinavica
|
September 29, 2021
Weight gain on antipsychotics - A perfect storm of complex pathophysiology and psychopharmacology
Bjørn H Ebdrup, Filip K Knop
Experimental Biology and Medicine (Maywood, N.J.)
|
November 1, 2013
Cardiovascular effects of alpha-linolenic acid--a possible role of glucagon-like peptide-1
David P Sonne, Filip K Knop
The Lancet. Gastroenterology & Hepatology
|
November 12, 2022
Liraglutide versus colesevelam for treating bile acid diarrhoea - Authors' reply
Martin L Kårhus, Filip K Knop
Diabetes Care
|
November 26, 2015
Comment on Xu et al. Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care 2015;38:1858-1867
David P Sonne, Filip K Knop
Page
of 44
Search research articles
Search
Showing results (11-20 of 433) with videos related to
Sort By:
Page
of 44
Diabetes
|
August 28, 2012
Comment on: Gögebakan et al. Glucose-dependent insulinotropic polypeptide reduces fat-specific expression and activity of 11β-hydroxysteroid dehydrogenase type 1 and inhibits release of free fatty acids. Diabetes 2012;61:292-300
Filip K Knop, Mikkel Christensen
Diabetes Research and Clinical Practice
|
June 27, 2018
Extrapancreatic glucagon: Present status
Asger Lund, Filip K Knop
Current Medical Research and Opinion
|
April 3, 2012
Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea
Asger Lund, Filip K Knop
Lancet (London, England)
|
January 10, 2012
The unobtainable placebo: control of independent clinical research by industry?
Mikkel Christensen, Filip K Knop
Vitamins and Hormones
|
November 25, 2010
Incretin-based therapy and type 2 diabetes
Kristine J Hare, Filip K Knop
European Journal of Endocrinology
|
August 2, 2019
A role for exogenous GLP-1 in the management of postprandial hypoglycaemia after Roux-en-Y gastric bypass?
Caroline C Øhrstrøm, Filip K Knop
Acta Psychiatrica Scandinavica
|
September 29, 2021
Weight gain on antipsychotics - A perfect storm of complex pathophysiology and psychopharmacology
Bjørn H Ebdrup, Filip K Knop
Experimental Biology and Medicine (Maywood, N.J.)
|
November 1, 2013
Cardiovascular effects of alpha-linolenic acid--a possible role of glucagon-like peptide-1
David P Sonne, Filip K Knop
The Lancet. Gastroenterology & Hepatology
|
November 12, 2022
Liraglutide versus colesevelam for treating bile acid diarrhoea - Authors' reply
Martin L Kårhus, Filip K Knop
Diabetes Care
|
November 26, 2015
Comment on Xu et al. Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care 2015;38:1858-1867
David P Sonne, Filip K Knop
Page
of 44